David Fivenson, MD, PLC

Ann Arbor, Michigan 48103

1 studies enrolling now · 8 studies all time

What they study most

Atopic Dermatitis, Bullous Pemphigoid, Overweight or Obesity, Papulopustular Rosacea, Plaque Psoriasis, Psoriasis, Psoriasis Vulgaris

Studies at this site

• A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) — Recruiting now
• Nomacopan Therapy in Adult Patients With Bullous Pemphigoid Receiving Adjunct Oral Corticosteroid Therapy (ARREST-BP) — Withdrawn before enrolling
• LEO 90100 Compared With Calcipotriol Plus Betamethasone Dipropionate Ointment, LEO 90100 Vehicle and Ointment Vehicle in Subjects With Psoriasis Vulgaris — Completed
• LEO 90100 in the Treatment of Psoriasis Vulgaris — Completed
• A Comparison of DFD01 Spray Versus Comp01 Lotion, Vehicle Spray and Vehicle Lotion in Subjects With Moderate Psoriasis — Completed
• A Comparative Study Between ABP 501 and Humira® in Participants With Moderate to Severe Plaque Psoriasis — Completed
• Phase 3 Papulopustular Rosacea Study — Completed
• Study of Equivalence of Generic Pimecrolimus Cream 1% and Elidel® 1% in Subjects With Mild to Moderate Atopic Dermatitis — Completed